Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.75M Buy
2,389
+5
+0.2% +$7.96K 0.32% 84
2026
Q1
$3.53M Sell
2,384
-1,305
-35% -$1.79M 0.21% 120
2025
Q4
$3.95M Sell
3,689
-1,276
-26% -$1.33M 0.26% 91
2025
Q3
$4.81M Buy
4,965
+2,524
+103% +$1.98M 0.32% 79
2025
Q2
$1.96M Buy
+2,441
New +$1.75M 0.15% 140
2023
Q4
Sell
-1,009
Closed -$594K 186
2023
Q3
$594K Sell
1,009
-3,267
-76% -$2.17M 0.14% 97
2023
Q2
$3.1M Buy
4,276
+1,638
+62% +$1.11M 0.67% 40
2023
Q1
$1.8M Buy
2,638
+2,634
+65,850% +$1.69M 0.45% 58
2022
Q4
$2.19K Buy
+4
New +$2.1K ﹤0.01% 678

Other funds holding ASML

Fiduciary Alliance's ASML Position: Q2 2026 in Review

Fiduciary Alliance increased its ASML (ASML) stake by 0.21% in Q2 2026, buying an estimated $7.96K and bringing the position to 2,389 shares worth $4.75M. The position accounts for 0.32% of the portfolio, ranked #84.

Fiduciary Alliance first reported a position in ASML in Q4 2022 and has held it in 9 quarters since. The position peaked at $4.81M in Q3 2025. 443 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Fiduciary Alliance held 2,389 shares of ASML worth $4.75M as of Q2 2026.
  • Fiduciary Alliance bought 5 ASML shares in Q2 2026, an estimated $7.96K.
  • ASML made up 0.32% of Fiduciary Alliance's portfolio in Q2 2026, its #84 holding.
  • Fiduciary Alliance first reported a position in ASML in Q4 2022 and has held it in 9 quarters since.
  • Fiduciary Alliance's ASML position peaked at $4.81M in Q3 2025.
  • 443 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.